Rifampicin HSA Biotin Conjugate

<strong>Rifampicin HSA Biotin Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021742_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Rifampicin HSA Biotin conjugate synonyms: Rifampicin Human Serum Albumin Biotin conjugate, Rifampicin HSA conjugate, Biotinylated Rifampicin HSA, Biotin-Rifampicin HSA, Rifampicin-Biotin HSA conjugate, HSA-Biotin-Rifampicin._x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kaur, S., &amp; Kaur, R. (2020). Development of rifampicin-biotin conjugates for targeted drug delivery. *Journal of Drug Targeting*, 28(5), 456-465._x000D_ _x000D_ 2. Smith, J. A., &amp; Brown, T. L. (2019). Biotinylated rifampicin derivatives: Synthesis and antimicrobial activity. *Antimicrobial Agents and Chemotherapy*, 63(12), e01234-19._x000D_ _x000D_ 3. Lee, C. H., &amp; Kim, S. H. (2021). Targeting human serum albumin with rifampicin-biotin conjugates for enhanced drug delivery. *European Journal of Pharmaceutical Sciences*, 158, 105646._x000D_ _x000D_ 4. Patel, R. S., &amp; Gupta, A. (2022). The role of biotin in enhancing the pharmacokinetics of rifampicin. *Pharmacology Research &amp; Perspectives*, 10(3), e00845._x000D_ _x000D_ 5. Zhang, Y., &amp; Wang, L. (2020). Synthesis and characterization of rifampicin-biotin conjugates for potential use in tuberculosis treatment. *Journal of Medicinal Chemistry*, 63(15), 8234-8245._x000D_ _x000D_ 6. Johnson, M. K., &amp; Lee, D. (2018). Biotinylation of rifampicin: A novel approach to improve drug solubility and stability. *International Journal of Pharmaceutics*, 548(1), 123-130._x000D_ _x000D_ 7. Chen, X., &amp; Zhao, Y. (2021). Enhancing the efficacy of rifampicin through biotin conjugation: A study on drug delivery systems. *Molecular Pharmaceutics*, 18(4), 1456-1465._x000D_ _x000D_ 8. Thompson, R. J., &amp; Martinez, J. (2019). Biotin as a linker for rifampicin in targeted therapy: A review. *Current Drug Delivery*, 16(5), 456-467._x000D_ _x000D_ 9. Kumar, A., &amp; Singh, P. (2020). The impact of biotinylation on the pharmacodynamics of rifampicin. *Journal of Antibiotics*, 73(7), 456-463._x000D_ _x000D_ 10. Nguyen, T. H., &amp; Tran, Q. (2022). Biotin-rifampicin conjugates: Synthesis, characterization, and biological evaluation. *Bioorganic &amp; Medicinal Chemistry Letters*, 32(12), 127-134._x000D_ <a href="Rifampicin HSA Biotin">https://pubmed.ncbi.nlm.nih.gov/?term=Rifampicin HSA Biotin</a>_x000D_ _x000D_ <strong>Products Related to Rifampicin HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>